There is fair evidence to recommend screening adults with hypertension for type 2 diabetes to reduce the incidence of cardiovascular (CV) events and mortality.
(Grade B recommendation)
There is fair evidence to recommend screening adults with hyperlipidemia for type 2 diabetes to reduce the incidence of CV events and mortality.
(Grade B recommendation)
There is good evidence to recommend treatment of overweighti individuals with impaired glucose tolerance (IGT) with lifestyle interventions to reduce the incidence of diabetes progression.
(Grade B recommendation)
There is sufficient evidence to recommend treatment of overweighti individuals with IGT with metformin or acarbose to reduce the incidence of diabetes progression.
(Grade I recommendation)
There is fair evidence to recommend treatment of overweighti individuals with IGT with acarbose to prevent cardiovascular outcomes and hypertension.
(Grade B recommendation)